Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Gastroenterology Research and Practice
|
June 17, 2024
The Short-Term and Long-Term Outcomes of Laparoscopy-Assisted Proximal Gastrectomy with Double-Tract Reconstruction versus Laparoscopy-Assisted Total Gastrectomy with Roux-en-Y Reconstruction for Adenocarcinoma of the Esophagogastric Junction: A Multicenter Study Based on Propensity Score Matching Analysis
Zhiwen Xu, Wei Lin, Su Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 6, 2022
Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era
Zhiqiang Song, Lili Xu, Gusheng Tang, et al.
Immunotherapy
|
August 6, 2020
Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma
Tao Wang, Lei Gao, Yujie Wang, et al.
Biochemical Pharmacology
|
January 12, 2011
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells
Qiang Wang, Xiaobing Liu, Qingduan Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2019
Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation
Tao Wang, Lei Gao, Xiaoxia Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2011
Synthesis and anti-HIV-1 activity of 4-substituted-7-(2'-deoxy-2'-fluoro-4'-azido-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine analogues
Xiaohe Guo, Yujiang Li, Le Tao, et al.
Frontiers in Oncology
|
October 17, 2022
The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy
Yang Wang, Zhiqiang Song, Yuke Geng, et al.
Hematological Oncology
|
February 10, 2022
Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study
Tao Wang, Lili Xu, Lei Gao, et al.
Frontiers in Oncology
|
April 3, 2023
Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study
Xiangling Wang, Ting Wang, Yunxia Chu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 26, 2011
[A multicenter randomized phase II trial of domestic product of nrhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Mei Hou, Lu Li, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Gastroenterology Research and Practice
|
June 17, 2024
The Short-Term and Long-Term Outcomes of Laparoscopy-Assisted Proximal Gastrectomy with Double-Tract Reconstruction versus Laparoscopy-Assisted Total Gastrectomy with Roux-en-Y Reconstruction for Adenocarcinoma of the Esophagogastric Junction: A Multicenter Study Based on Propensity Score Matching Analysis
Zhiwen Xu, Wei Lin, Su Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 6, 2022
Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era
Zhiqiang Song, Lili Xu, Gusheng Tang, et al.
Immunotherapy
|
August 6, 2020
Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma
Tao Wang, Lei Gao, Yujie Wang, et al.
Biochemical Pharmacology
|
January 12, 2011
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells
Qiang Wang, Xiaobing Liu, Qingduan Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2019
Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation
Tao Wang, Lei Gao, Xiaoxia Hu, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2011
Synthesis and anti-HIV-1 activity of 4-substituted-7-(2'-deoxy-2'-fluoro-4'-azido-β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine analogues
Xiaohe Guo, Yujiang Li, Le Tao, et al.
Frontiers in Oncology
|
October 17, 2022
The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy
Yang Wang, Zhiqiang Song, Yuke Geng, et al.
Hematological Oncology
|
February 10, 2022
Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study
Tao Wang, Lili Xu, Lei Gao, et al.
Frontiers in Oncology
|
April 3, 2023
Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study
Xiangling Wang, Ting Wang, Yunxia Chu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 26, 2011
[A multicenter randomized phase II trial of domestic product of nrhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Mei Hou, Lu Li, et al.
Page
of 7